Medtech Opportunity In Asia For Patient Data, AI Advancement

The co-founder of Pure Global discusses the regulatory consultancy's use of AI to support clients’ marketing submissions and other needs, as well as the AI-enabled medtech landscape and opportunities in China and Southeast Asia for accessing patient data for AI development purposes.

DJ Fang, chief operating officer and co-founder of AI-powered regulatory consultancy Pure Global, says softer regulations in China and Southeast Asia can mean readier access to patient data, which is in growing demand as medtechs and their partners work to train AI algorithms.

Compared with the US and Europe where regulations around data privacy and informed consent are more stringent, “what you find...

More from AI

More from Leadership